TrademarkDir
ATT
LIVE

Serial Number

90764099

Owner

MARIUS PHARMACEUTICALS, INC.

Attorney

Jeffrey J. Ellison

First Use Date

Sep 21, 2022

Filing Date

Jun 9, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

ATT Trademark

Serial Number: 90764099 • Registration: 6919528

ATT is a trademark filed by MARIUS PHARMACEUTICALS, INC. on June 9, 2021. The trademark is classified under Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

MARIUS PHARMACEUTICALS, INC. (9 trademarks)

2301 SUGAR BUSH ROAD, #510
RALEIGH, NC 27612-3382

Entity Type: 03

Marius Pharmaceuticals, LLC (18 trademarks)

8601 Six Forks Road, Suite 630
Raleigh, NC 27615

Entity Type: 16

Trademark Details

Filing Date

June 9, 2021

Registration Date

December 6, 2022

First Use Anywhere

September 21, 2022

First Use in Commerce

September 21, 2022

Published for Opposition

February 15, 2022

Goods & Services

Printed materials, namely, brochures, booklets, and teaching materials in the field of achieving endocrine balance

Providing a website featuring medical information in the field of achieving endocrine balance

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 29, 2025 ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Jan 29, 2025 ASCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 18, 2024 ASGN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 12, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 12, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 12, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 12, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jan 12, 2024 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 6, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 6, 2022 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Nov 2, 2022 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Nov 1, 2022 CNPR
ASSIGNED TO EXAMINER
Oct 27, 2022 DOCK
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 25, 2022 EXRA
STATEMENT OF USE PROCESSING COMPLETE
Oct 24, 2022 SUPC
SOU EXTENSION 1 GRANTED
Oct 24, 2022 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 24, 2022 AITU
USE AMENDMENT FILED
Oct 12, 2022 IUAF
SOU EXTENSION 1 FILED
Oct 12, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 12, 2022 EEXT
TEAS STATEMENT OF USE RECEIVED
Oct 12, 2022 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 12, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 26, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 7, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 7, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 7, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 7, 2022 CNEA
ASSIGNED TO EXAMINER
Jan 7, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 30, 2021 NWOS

Related Trademarks

More from this Owner

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A CHRONIC DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE

TESTOSTERONE DEFICIENCY IS A DISEASE